Scarica l'app Stockscreener
1.09
7.63%
-0.09
Dopo l'orario di chiusura:
1.08
-0.01
-0.92%
Precedente Chiudi:
$1.18
Aprire:
$1.15
Volume 24 ore:
214.44K
Relative Volume:
0.78
Capitalizzazione di mercato:
$13.20M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-0.91%
1M Prestazione:
+43.40%
6M Prestazione:
+29.72%
1 anno Prestazione:
-92.04%
Intervallo 1D:
$1.02
$1.155
Intervallo di 1 settimana:
$1.02
$1.25
Portata 52W:
$0.375
$16.06
AEON Biopharma Inc. Stock (AEON) Company Profile
Nome
AEON Biopharma Inc.
Settore
Industria
Telefono
(949) 354-6499
Indirizzo
5 Park Plaza, Suite 1750, Irvine
Confronta AEON con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AEON
AEON Biopharma Inc.
|
1.09 | 14.28M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-08-18 | Iniziato | H.C. Wainwright | Buy |
AEON Biopharma Inc. Borsa (AEON) Ultime notizie
Why AEON Biopharma Inc. Class stock stays on buy listsJuly 2025 Trends & Low Drawdown Investment Ideas - ulpravda.ru
Will AEON Biopharma Inc. Class stock outperform foreign stocksWeekly Stock Report & Low Drawdown Trading Strategies - ulpravda.ru
What technical signals suggest for AEON Biopharma Inc. stockGDP Growth & Momentum Based Trading Ideas - ulpravda.ru
Midday Stock Roundup: Lantronix Stock up 4.8% Today - Orange County Business Journal
What dividend safety rating applies to AEON Biopharma Inc. Class stockWeekly Earnings Recap & Low Risk Entry Point Guides - ulpravda.ru
What insider trading reveals about AEON Biopharma Inc. stockHigh Yield Income Stocks & Ride the Wave of Market-Beating Growth - ulpravda.ru
2026 world cup star players explained: How AEON Biopharma Inc. Class stock compares with tech leaders2026 world cup usa national team third place match key players pressing system expert forecast preview - ulpravda.ru
2026 world cup match report guide: How AEON Biopharma Inc. stock benefits from global expansion2026 world cup usa national team semifinals defensive leaders pressing system winner prediction preview - ulpravda.ru
Can AEON Biopharma Inc. Class stock stage a strong rebound this quarter2026 world cup usa national team qualification playmakers high defensive line odds analysis preview - ulpravda.ru
Midday Stock Roundup: Rivian Down on Production Totals - Orange County Business Journal
AEON Biopharma, Inc. (AEON) Stock Forecast & Price Prediction 2025–2030 - CoinCodex
AEON Biopharma (NASDAQ:AEON) Trading Up 5.9% – Time to Buy? - Defense World
AEON Biopharma (AEON) seeks shareholder approval for PIPE, note exchange and equity plan - Stock Titan
Will AEON Biopharma Inc. stock split attract more investorsMomentum Trading Signals & Grow Generational Wealth With Ease - bollywoodhelpline.com
Midday Stock Roundup: Shimmick Corp. climbs 14% - Orange County Business Journal
Aug EndMonth: How AEON Biopharma Inc stock benefits from global expansionWeekly Profit Recap & Risk Managed Investment Strategies - moha.gov.vn
Insider Buy: Can AEON Biopharma Inc Class stock stage a strong rebound this quarterJuly 2025 Rallies & Low Drawdown Trading Techniques - moha.gov.vn
Is AEON Biopharma Inc. Class stock bottoming after sell offBond Market & Community Verified Trade Signals - Улправда
Investor Mood: Can AEON Biopharma Inc. Class stock stage a strong rebound this quarter - Улправда
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - The Manila Times
How AEON Biopharma Inc. stock benefits from global expansionEarnings Recap Summary & Weekly High Potential Stock Alerts - Улправда
AEONAeon Biopharma Latest Stock News & Market Updates - Stock Titan
Will AEON Biopharma Inc. Class stock benefit from infrastructure billWeekly Trading Summary & Reliable Breakout Stock Forecasts - Улправда
Biopharmaceutical company offers new hires stock units over four years - Stock Titan
[PRE 14A] AEON Biopharma, Inc. Preliminary Proxy Statement - Stock Titan
Midday Stock Roundup: Rivian Stock Continues to Climb - Orange County Business Journal
Is AEON Biopharma Inc. Class stock undervalued historicallyEarnings Overview Summary & Pattern Based Trade Signal System - DonanımHaber
Will AEON Biopharma Inc. Class stock sustain dividend payoutsJuly 2025 Analyst Calls & Long Hold Capital Preservation Plans - DonanımHaber
Will AEON Biopharma Inc. stock recover faster than marketMarket Sentiment Review & Smart Allocation Stock Reports - DonanımHaber
AEON Biopharma Earnings Notes - Trefis
AEON Biopharma Announces Execution of Exchange Agreement with Daewoong - The Manila Times
AEON Biopharma IncExchange to Eliminate Ov - 富途牛牛
AEON Biopharma announces execution of exchange agreement with Daewoong Pharmaceutical - MSN
Aeon Biopharma announces execution of exchange agreement with Daewoong - marketscreener.com
AEON Biopharma Announces Exchange Agreement with Daewoong - TipRanks
AEON Biopharma announces exchange agreement with Daewoong - MSN
AEON Biopharma signs Daewoong note exchange with equity and warrants | AEON SEC FilingForm 8-K - Stock Titan
AEON Biopharma (NYSE: AEON) agrees Daewoong swap cutting over 90% of debt - Stock Titan
AEON and Daewoong finalize $15 million debt-to-equity exchange deal - Investing.com
Aeon Biopharma Continues Push to Commercialization - Orange County Business Journal
AEON Biopharma (AEON) Price Target Decreased by 15.28% to 6.22 - Nasdaq
AEON Biopharma Releases New Corporate Presentation - The Globe and Mail
How AEON Biopharma Inc. Class stock performs in volatility spikesQuarterly Market Review & Fast Gain Stock Trading Tips - Newser
Can AEON Biopharma Inc. Class stock retain market dominanceJuly 2025 Summary & Trade Opportunity Analysis Reports - Newser
AEON Biopharma : Corporate Presentation - marketscreener.com
AEON Biopharma (NYSE: AEON) releases new investor Corporate Presentation - Stock Titan
AEON Biopharma Inc. Azioni (AEON) Dati Finanziari
Non sono disponibili dati finanziari per AEON Biopharma Inc. (AEON). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.80%
4.56%
Capitalizzazione:
|
Volume (24 ore):